Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore
posted on 2019-01-01, 00:00authored bySil-ling PruisSil-ling Pruis, Mohamed Ismail Abdul Aziz, Fiona Pearce, Min Han Tan, David Bin-Chia Wu, Kwong Ng
Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore
History
Journal
International Journal of Technology Assessment in Health Care